AKTX

AKTX

Akari Therapeutics plc ADS

$1.171+0.000 (0.017%)

Prix en Temps Réel

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.171

Haut

$1.171

Bas

$1.171

Volume

0.04M

Fondamentaux de l'Entreprise

Statistiques de Trading

Actualités Connexes

GlobeNewswire

Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Advancing development of novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads to treat multiple cancer tumors Rounding out executive team with deep oncology experience by appointing new Head of Business

Voir plus
Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody

Voir plus
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology